Alpha tocotrienol quinone: Phase IIa started

Edison began a double-blind, placebo-controlled Phase IIa trial to evaluate 15 mg/kg EPI-743 thrice daily in about 20 female patients aged <18 years. Last month, Edison granted Dainippon exclusive rig...